Transaction in Own Shares

RNS Number : 9090T

GlaxoSmithKline PLC

13 December 2011

 



GlaxoSmithKline plc (the "Company") announces that in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 5^th May 2011, it cancelled 30,000,000 of its Ordinary shares of 25 pence each held as Treasury shares on 13 December 2011.

Following the above transactions, the Company holds 501,157,927of its shares in Treasury, representing 9.03% of the total issued share capital of the Company and 9.93% of the total voting rights.

The Company has 5,047,261,460 shares in issue (excluding Treasury shares). This number represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in the Company under the Financial Services Authority's Disclosure and Transparency Rules.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer to purchase or subscribe for securities in any jurisdiction and is in conformity with the Financial Services Authority's Disclosure and Transparency Rules.

 

END

 

 

POSLLFLDFTLVLIL